TY - JOUR
T1 - Lesions of the Corpus Callosum in Children With Neurofibromatosis 1
AU - Mimouni-Bloch, Aviva
AU - Kornreich, Liora
AU - Kaadan, Walid
AU - Steinberg, Tamar
AU - Shuper, Avinoam
PY - 2008/6
Y1 - 2008/6
N2 - Our aim was to determine the rate of focal lesions of the corpus callosum in children with neurofibromatosis type 1, and to characterize their natural history. Magnetic resonance imaging scans of the brain in 79 children with neurofibromatosis type 1 who were followed at the Neurology Clinic of Schneider Children's Medical Center (Petah Tiqwa, Israel) from 1990-2005 were reviewed. Focal lesions of the corpus callosum were identified in 11 (14%). These included unidentified bright objects in 7 patients (9%), and a neoplastic process in 4 (5%). Follow-up ranged from 1-16 years. Two of 4 tumors had enlarged during follow-up, and one was excised. Neurofibromatosis type 1 may be associated with a 14% prevalence of corpus callosum lesions. Owing to the apparently high frequency of callosal neoplasms in this population (5% in our series), and their tendency to enlarge, careful evaluation and prolonged follow-up are warranted.
AB - Our aim was to determine the rate of focal lesions of the corpus callosum in children with neurofibromatosis type 1, and to characterize their natural history. Magnetic resonance imaging scans of the brain in 79 children with neurofibromatosis type 1 who were followed at the Neurology Clinic of Schneider Children's Medical Center (Petah Tiqwa, Israel) from 1990-2005 were reviewed. Focal lesions of the corpus callosum were identified in 11 (14%). These included unidentified bright objects in 7 patients (9%), and a neoplastic process in 4 (5%). Follow-up ranged from 1-16 years. Two of 4 tumors had enlarged during follow-up, and one was excised. Neurofibromatosis type 1 may be associated with a 14% prevalence of corpus callosum lesions. Owing to the apparently high frequency of callosal neoplasms in this population (5% in our series), and their tendency to enlarge, careful evaluation and prolonged follow-up are warranted.
UR - http://www.scopus.com/inward/record.url?scp=43449116902&partnerID=8YFLogxK
U2 - 10.1016/j.pediatrneurol.2008.02.010
DO - 10.1016/j.pediatrneurol.2008.02.010
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:43449116902
SN - 0887-8994
VL - 38
SP - 406
EP - 410
JO - Pediatric Neurology
JF - Pediatric Neurology
IS - 6
ER -